Diabetes Information

Pancreas Transplants - A Solution For Type 1 Diabetes Sufferers?


Type 1 diabetes was formerly known as juvenile diabetes or insulin dependent diabetes mellitus. Type 1 diabetes matures quickly and symptoms are very visible.

This type of diabetes occurs when the body's immune system destroys pancreatic cells. These cells are the insulin producing cells. This type of diabetes affects mostly children and young adults. Risk factors for type1 diabetes include autoimmune, genetics, and environmental factors.

Many clinical studies have shown that an option for type 1 diabetes treatment is the pancreas transplantation. For some patients, surgeons can restore the function of the pancreas with an islet cell transplant.

The most important benefit of pancreas transplantation is freedom from dependence on insulin. Although this is significant, this is not recommended treatment for diabetes unless there is a need for a kidney transplant as well.

On the other hand, pancreas transplants still remains problematic in that the immune system still can attack new pancreas cells. Some people who have transplants do find that the transplanted pancreas is attacked and the insulin-producing cells are killed off after operation.

At this time, pancreas transplants do not always provide permanent cures, and people who have transplants must take anti-rejection medication and immune-system suppressing drugs.

Many research teams are still working on this immune system problem that seems to be the root cause of type 1 diabetes (sometimes called auto-immune diabetes).

This is main reason that pancreas transplants are still only being studied experimentally and are not considered currently to be an automatic cure for all patients with type 1 diabetes.

Valerian, freelance writer specialized in health issues affecting men
http://www.mens-health-events.info/diabetes.php


MORE RESOURCES:

MiamiHerald.com

Corporate Watch
Wall Street Journal
Despite clinical data suggesting a link between Seroquel and increased risk for diabetes, AstraZeneca's primary legal argument is that there is no evidence ...
AstraZeneca Wins Trial on Seroquel Diabetes ClaimBusinessWeek
AstraZeneca wins US liability case on SeroquelReuters
AstraZeneca wins 1st trial over alleged drug harmThe Associated Press
Drug Store News -ONN.tv -RTT News
all 163 news articles »


World News

Manage diabetes to preventing heart disease and stroke
The Morning Sun
By MIDMICHIGAN HEALTH Heart disease is common in people with diabetes, but the good news is that taking good care of diabetes and the body today can help ...
Right Knowledge and Conduct is the Key to Survive with DiabetesTopNews United States
Online, Phone Tests Assess Diabetes RiskBusinessWeek
Education, behavior key to living with diabetesNews-Herald.com
Medscape -UPI.com -About - News & Issues (blog)
all 112 news articles »



Quad-Cities Online

Health department home health staff note American Diabetes Alert Day
Quad-Cities Online
The Henry and Stark County Health Departments' Home Health Nursing staff announce that Tuesday, March 23rd has been proclaimed the American Diabetes Alert ...
Diabetes health fair Saturday -- at the cemeteryAustin American-Statesman (blog)
'Diabetes Alert Day' is March 23TriValley Central
"The silent killer"San Jose Mercury News
Medical News Today (press release) -Diabetes.co.uk -Marketwire (press release)
all 16 news articles »


India Talkies

Selenium Could Shield Against Diabetes
BusinessWeek
THURSDAY, March 18 (HealthDay News) -- Scientists have found evidence that older men with higher levels of selenium are less likely to suffer from ...
Dietary supplement can reduce diabetes risk – but only in menTelegraph.co.uk
Selenium may help fight diabetes in menTimes of India
Dietary Supplement Can Lower Risk of Diabetes Just in MenDiet.co.uk
eMaxHealth -Diabetes.co.uk -TopNews United States
all 31 news articles »


Daily Contributor

FDA Rejects Amylin Diabetes Drug, Seeks More Info
Wall Street Journal
NEW YORK (Dow Jones)--The US Food and Drug Administration denied approval of a long-acting version of diabetes drug ...
Diabetes Drug From Lilly, Amylin Under ScrutinyForbes
FDA asks for risk plan info on diabetes drugThe Associated Press
Alkermes, others rise on Byetta newsBoston Globe
BusinessWeek -Cincinnati.com -Xconomy
all 313 news articles »


Reuters

A Diagnosis of Pre-Diabetes Isn't Enough to Motivate Many Patients
Diabetes Health (press release)
In a study that tracked 1402 people with pre-diabetes, researchers found that only about half of them responded to the diagnosis by trying to shed weight or ...
Diabetes Mellitus - an increasing problemLiberty County Times
Blood exam predicts risk for diabetesPaducah Sun
Are You At Risk For Diabetes?NJ TODAY
Reuters -Gather.com -India Infoline.com
all 26 news articles »


Bristol combination diabetes drug under review
BusinessWeek
Onglyza, made by Bristol-Myers and AstraZeneca, is already approved as a diabetes treatment and metformin is a widely-used generic diabetes pill. ...
FDA Approves Another Type 2 Diabetes Drug ApplicationeMaxHealth
Bristol-Myers Squibb, AstraZeneca Say FDA Accepts NDA For An Onglyza ...RTT News
Market Report -- In Play (BMY)MSN Money
News-Medical.net -Drug Store News
all 22 news articles »


Studies: Drugs don't reduce heart problems for diabetes patients
USA Today
They involve people with Type 2 diabetes — the most common form and the one rising because of the obesity epidemic. Diabetics have more than double the risk ...

and more »


Has Roche Given Up On Diabetes Devices?
Forbes
Listening to O'Day speak one would never know that Roche is even in the business of diabetes devices. Granted this unit has struggled mightily over the past ...


Google News

home | site map
© 2006